» Articles » PMID: 35257463

Incidence and Risk Factor Analysis of Complications After Sentinel Node Biopsy for Penile Cancer

Overview
Journal BJU Int
Specialty Urology
Date 2022 Mar 8
PMID 35257463
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the incidence and types of complications after dynamic sentinel node biopsy (DSNB) in patients with penile cancer (PeCa) and identify risk factors for the occurrence of postoperative complications.

Patients And Methods: We evaluated 644 patients with PeCa (1284 DSNB procedures) with at least one clinically node negative (cN0) groin who underwent DSNB between 2011 and 2020 at a single high-volume centre. The 30- and 30-90-day postoperative complications were collected according to the modified Clavien-Dindo classification and the standardised methodology proposed by the European Association of Urology panel. Uni- and multivariable generalised linear mixed models were used to identify risk factors for the occurrence of complications per groin.

Results: A 30-day postoperative complication occurred in 14% of groins (n = 186), of which 94% were mild to moderate. Wound infection and lymphocele formation were most common. A 30-90-day postoperative complication occurred in 3.4% of the groins, all of which were mild or moderate (Grade I-II). The number of removed lymph nodes (LNs) per groin was the main independent predictor for any 30-day complications and Grade ≥II complications (odds ratio 1.40; P < 0.001). There was an increase in the probability of postoperative complications with the number of LNs removed after accounting for all confounders.

Conclusions: Despite being less morbid than (modified) inguinal LN dissection, DSNB is still associated with a considerable risk of postoperative mild-to-moderate complications. This risk increases with increasing number of LNs removed. Further procedural refinement aimed at removing the true sentinel node(s) only, may help further reduce the morbidity of surgical staging in PeCa.

Citing Articles

Minimally Invasive Management of Inguinal Lymph Nodes in Penile Cancer: Recent Progress and Remaining Challenges.

Aydin A, Biben E, Yu A, Chakiryan N, Mehrazin R, Spiess P Cancers (Basel). 2024; 16(17).

PMID: 39272796 PMC: 11394048. DOI: 10.3390/cancers16172935.


[Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study.

Eismann L, Ledderose S, Enzinger B, Berg E, Westhofen T, Rodler S Eur J Nucl Med Mol Imaging. 2024; 51(11):3461-3464.

PMID: 38761187 DOI: 10.1007/s00259-024-06763-1.


New EAU/ASCO guideline recommendations on sentinel node biopsy for penile cancer and remaining challenges from a nuclear medicine perspective.

Vreeburg M, Donswijk M, Albersen M, Parnham A, Ayres B, Protzel C Eur J Nucl Med Mol Imaging. 2024; 51(10):2861-2868.

PMID: 38216778 DOI: 10.1007/s00259-023-06586-6.


The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature search.

Sarcan S, Wolff I, Lusuardi L, Kravchuk A, Wiegland J, Yakac A World J Urol. 2024; 42(1):12.

PMID: 38189947 DOI: 10.1007/s00345-023-04719-y.


The role of radiotherapy in the management of squamous cell cancer of the penis.

Crook J World J Urol. 2023; 41(12):3913-3920.

PMID: 37994970 DOI: 10.1007/s00345-023-04683-7.